Press Releases

  • Volition Extends Global Reach of its Clinical Trial Program

  • Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region

  • VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018

  • VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update

  • VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits

  • VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update

  • VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock

  • VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock

  • VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

  • VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board

arrow-downarrow-leftarrow-rightarrowchevron-downcircle-link--redcircle-linkcloseplayplus